Daphne Koller Unveils AI's Potential to Transform Drug Discovery
AI in Pharmaceuticals: A New EraOn April 29, 2026, Daphne Koller, a prominent figure in the field of artificial intelligence, shared her insights on the profound implications of AI in drug discovery.
AI's integration into drug discovery could significantly reduce costs and improve patient health outcomes by accelerating the development of new treatments.
